EDG Capital, Inc Announces Filing of Investigational New Drug Application With FDA
(Business Wire)EDG Capital, Inc., a developer of nuclear pharmaceuticals for therapeutic use in the treatment of cancer, announced today that, on June 4, 2001, its wholly owned subsidiary Isotope Solutions, Inc. filed an Investigational New Drug application with the Food and Drug Administration.- Jun 05 1:50 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010605/2917.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines